Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.
Not Applicable
Not yet recruiting
- Conditions
- NSCLC Brain Metastasis
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Target Recruit Count
- 200
- Registration Number
- NCT06716775
A Phase 1b Study of TTF in Combination With Durvalumab and GemCis in BTC.
Not Applicable
Recruiting
- Conditions
- Biliary Tract Cancers (BTC)
- Interventions
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2024-10-26
- Target Recruit Count
- 60
- Registration Number
- NCT06611345
- Locations
- 🇨🇳
Anhui Provincial Hospital, He Fei, China
TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
Phase 2
Recruiting
- Conditions
- Glioblastoma Multiforme
- Interventions
- First Posted Date
- 2024-04-09
- Last Posted Date
- 2024-08-09
- Target Recruit Count
- 30
- Registration Number
- NCT06353360
- Locations
- 🇨🇳
Huashan Hospital affiliated to Fudan University, Shanghai, China
Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields （EFE-P100）Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1（PD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody Treatment
Phase 2
Not yet recruiting
- Conditions
- Non-small Cell Lung Cancer (NSCLC)
- Interventions
- Device: Tumor treating fields（EFE-P100）
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2022-12-22
- Target Recruit Count
- 348
- Registration Number
- NCT05661240
- Locations
- 🇨🇳
Shanghai Pulmonary Hospital, Shanghai, China
Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer
Phase 3
Recruiting
- Conditions
- Locally Advanced Pancreatic Cancer
- Interventions
- Device: Tumor treating fields combined with Gemcitabine hydrochloride and albumin binding paclitaxel
- First Posted Date
- 2022-12-16
- Last Posted Date
- 2025-03-24
- Target Recruit Count
- 512
- Registration Number
- NCT05653453
- Locations
- 🇨🇳
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
🇨🇳Cancer Hospital of Shandong First Medical University, Jinan, Shandong, China
🇨🇳Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath